Standard BioTools Inc

Founded in 2004, Sutro Biopharma, Inc has raised over $59M in funding since its inception. Current investors include SV Life Sciences, Alta Partners, Skyline Ventures, and Lilly Ventures. Alta Partners is a leading venture capital firm in life sciences, funding over 120 companies in the industry since 1996. Alta's diverse and integrated team brings together a powerful depth of knowledge and experience, delivering tangible results for our companies and our investors. As an important component of Amgen's overall outreach strategy, Amgen Ventures invests in early-stage biotechnology companies focused on discovering and developing human therapeutics. The fund, which focuses primarily on areas of current therapeutic interest to Amgen, offers early-stage companies access to our extensive capabilities while providing us with insight into external research innovations that may pave the way for future collaborations.

Walking Fish Therapeutics, Inc. is a biotech company based in South San Francisco, CA, specializing in the development of cell-based therapeutics for the treatment of serious diseases, with a focus on oncology and regenerative therapies. They have created a powerful B cell platform that harnesses the production capabilities of B cells to deliver multiple potent therapeutic proteins, offering potential applications in various fields such as autoimmune diseases, infectious diseases, deficiency diseases, and cancer treatment. Co-founded and led by Lewis Rusty Williams, an experienced entrepreneur in the biotech industry, Walking Fish Therapeutics has assembled a distinguished team of experts in cell engineering, manufacturing, and clinical research, supported by renowned scientific and strategic advisors. With their deep understanding of B cell biology and critical advances in engineering technologies, Walking Fish is at the forefront of this emerging field, aiming to revolutionize the development of B cell therapies for multiple diseases.Generated from the website